Does NIVOLUMAB Cause Coagulopathy? 36 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 36 reports of Coagulopathy have been filed in association with NIVOLUMAB (OPDIVO). This represents 0.0% of all adverse event reports for NIVOLUMAB.
36
Reports of Coagulopathy with NIVOLUMAB
0.0%
of all NIVOLUMAB reports
15
Deaths
23
Hospitalizations
How Dangerous Is Coagulopathy From NIVOLUMAB?
Of the 36 reports, 15 (41.7%) resulted in death, 23 (63.9%) required hospitalization, and 8 (22.2%) were considered life-threatening.
Is Coagulopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIVOLUMAB. However, 36 reports have been filed with the FAERS database.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Coagulopathy?
RIVAROXABAN (1,002)
ACETAMINOPHEN (977)
DABIGATRAN ETEXILATE (718)
ASPIRIN (674)
WARFARIN (589)
METHOTREXATE (414)
VINCRISTINE (275)
APIXABAN (271)
CYCLOPHOSPHAMIDE (240)
PREDNISONE (228)
Which NIVOLUMAB Alternatives Have Lower Coagulopathy Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE